Work

“Time is of the essence”: physician challenges impact patient access to chimeric antigen receptor T-cell therapy

Year: 2026
Type: article
Abstract: BACKGROUND: CD19-directed chimeric antigen receptor T-cell therapy (CART) is a life-saving regimen for children with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL), yet children from lower socioeconomic and historically marginalized backgrounds are less likely to receive it. Understanding the provider experience of CART referral and post-CART clinical management is critical for designing effective interventions to improve access. OBJECTIVE: To explore physicians' experiences identifying and referring pediatric patients with r/r B-ALL for CART across diverse hospital settings, and to identify physician-perceived facilitators and barriers to CART treatment. STUDY DESIGN: Focus groups using a semi-structured guide were conducted with pediatric oncology physicians, recruited via email and at a national conference, with targeted recruitment of National Cancer Institute Community Oncology Research Program (NCORP) site providers. Questions explored identifying pediatric patients with r/r B-ALL as CART candidates, referring them for CART, and accessing institutional infrastructure to support referral. RESULTS: Analysis revealed six domains spanning referral to CART and subsequent CART treatment: identification of potentially eligible patients; complexity of CART referral; barriers to insurance approval; physician perception of patients' social/financial circumstances; and variability in pre- and post-CART management guidelines. Health system-level facilitators and barriers included patient identification and referral processes to tertiary care centers, guidelines for bridging therapy and post-CART toxicity management, and navigation support for patient care and insurance approval. CONCLUSION: Findings highlight challenges in community-based settings where resources, infrastructure and geographic availability for CART are variable. Standardizing referral pathways, centralizing trial information, and streamlining CART-center intake process and communication are of immediate importance.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,050
OpenAlex ID: W7236460291
FWCI:
Cites: 16
Cited by:
Related to: 10